PTAFR and cancer: The PAF-PAFR axis is largely associated with cancer progression (30), neoangiogenesis (31), modulation of the tumor microenvironment with downregulation of the anti-cancer immune response (32), and evasion of the chemoradiation-induced cell death (16, 33).